Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.
| Ticker / NAME | Correlation To CLYYF | 1D Price Change % | ||
|---|---|---|---|---|
| CLYYF | 100% | N/A | ||
| ELVAF - CLYYF | 47% Loosely correlated | N/A | ||
| REPL - CLYYF | 35% Loosely correlated | +6.21% | ||
| HLVX - CLYYF | 29% Poorly correlated | +7.74% | ||
| IBIO - CLYYF | 23% Poorly correlated | -6.25% | ||
| ATHE - CLYYF | 22% Poorly correlated | +9.76% | ||
More | ||||